Literature DB >> 2556822

Receptors that inhibit phosphoinositide breakdown.

J Linden, T M Delahunty.   

Abstract

Calcium-mobilizing receptors are believed to activate phospholipase C. Joel Linden and Thérèse Mary Delahunty summarize recent reports which indicate that activation of some receptors that inhibit the accumulation of Ca2+ within cells - notably receptors for adenosine, dopamine and several other neurotransmitters - can inhibit phosphoinositide metabolism. Two types of mechanism may be involved in these responses. Many instances of receptor-mediated inhibition of phosphoinositide breakdown can be detected only after a period of several minutes and may be secondary to receptor-mediated events that lower [Ca2+]i or activate certain protein kinases. In other instances the activation of receptors rapidly (within seconds) inhibits phosphoinositide breakdown, possibly via the activation of guanine nucleotide binding proteins that either directly, or by a rapid indirect action, inhibit phospholipase C. Putative mechanisms for direct and indirect regulation of phospholipase C are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556822     DOI: 10.1016/0165-6147(89)90209-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  17 in total

1.  Adenosine A1-receptor stimulation of inositol phospholipid hydrolysis and calcium mobilisation in DDT1 MF-2 cells.

Authors:  T E White; J M Dickenson; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

2.  Changes in phosphoinositide-specific phospholipase C and phospholipase A2 activity in ischemic and reperfused rat heart.

Authors:  D W Schwertz; J Halverson
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

3.  Pharmacological evidence that protein kinase C modulates monosynaptic excitations in the olfactory cortex.

Authors:  G G Collins; W J Richards
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Cholecystokinin activates Gi1-, Gi2-, Gi3- and several Gs-proteins in rat pancreatic acinar cells.

Authors:  S Schnefel; A Pröfrock; K D Hinsch; I Schulz
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

5.  Suppression of Gi alpha 2 enhances phospholipase C signalling.

Authors:  D C Watkins; C M Moxham; A J Morris; C C Malbon
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  G protein-mediated inhibition of phosphoinositide metabolism evoked by metabotropic glutamate receptors in frog oocytes.

Authors:  K Nakamura; T Nukada; T Haga; H Sugiyama
Journal:  J Physiol       Date:  1994-01-01       Impact factor: 5.182

7.  Lithium amplifies inhibitions of inositol phospholipid hydrolysis in mammalian brain slices.

Authors:  D A Kendall; P Whitworth
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

8.  gamma-Aminobutyric acid inhibition of histamine-induced inositol phosphate formation in guinea-pig cerebellum: comparison with guinea-pig and rat cerebral cortex.

Authors:  M L Crawford; H Carswell; J M Young
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

9.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Authors:  O Nikodijević; R Sarges; J W Daly; K A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

10.  Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin.

Authors:  M S Balda; L González-Mariscal; R G Contreras; M Macias-Silva; M E Torres-Marquez; J A García-Sáinz; M Cereijido
Journal:  J Membr Biol       Date:  1991-06       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.